Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium calcium edetate/Tobramycin combination therapy - Respirion Pharmaceuticals

Next Previous
Search
Drug Profile

Sodium calcium edetate/Tobramycin combination therapy - Respirion Pharmaceuticals

Alternative Names: Respirion; RSP-1502; Tobramycin + Calcium EDTA; Tobramycin + Calcium EDTA combination therapy; Tobramycin + Sodium calcium edetate - Respirion Pharmaceuticals​/Cystic Fibrosis Foundation; Tobramycin + Sodium calcium edetate combination therapy

Latest Information Update: 06 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Respirion Pharmaceuticals
  • Class Acetates; Aminoglycosides; Anti-infectives; Antibacterials; Antibronchitics; Antifibrotics; Ethylenediamines; Small molecules
  • Mechanism of Action Chelating agents; Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Cystic fibrosis

Most Recent Events

  • 22 Feb 2024 Phase-I/II clinical trials in Cystic fibrosis in Australia (Inhalation) (NCT06016088)
  • 22 Feb 2024 Phase-I/II clinical trials in Cystic fibrosis in USA (Inhalation) (NCT06016088)
  • 05 Sep 2023 Clinical development is ongoing in Australia (Respirion Pharmaceuticals website, September 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top